Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Vaso-Occlusive Crises 1 Neoplasms 1 Diarrhea 1 Anemia, Sickle Cell 1

Interventions

Octreotide 3 Irinotecan 2 maltodextrin 1 lanreotide 1 PHY 906 1 Leucovorin 1 Lapatinib 1 Fluorouracil 1 Drugs, Investigational 1 Capecitabine 1 Calcium Aluminosilicate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Diarrhea × maltodextrin × Clear all

NCT02819960 2022-12-14

Prevention of Irinotecan Induced Diarrhea by Probiotics

S&D Pharma SK s.r.o.

Phase 3 Completed

Diarrhea, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡